Gregory A Deener - Net Worth and Insider Trading
Gregory A Deener Net Worth
The estimated net worth of Gregory A Deener is at least $25 dollars as of 2024-11-10. Gregory A Deener is the Vice President of Oncternal Therapeutics Inc and owns about 20 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $25. Details can be seen in Gregory A Deener's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory A Deener has not made any transactions after 2010-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gregory A Deener
Gregory A Deener Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory A Deener owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Gregory A Deener’s form 4 insider trades.
Insider Ownership Summary of Gregory A Deener
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2010-05-27 | Vice President |
Gregory A Deener Latest Holdings Summary
Gregory A Deener currently owns a total of 1 stock. Gregory A Deener owns 20 shares of Oncternal Therapeutics Inc (ONCT) as of May 27, 2010, with a value of $25.
Latest Holdings of Gregory A Deener
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2010-05-27 | 20 | 1.27 | 25 |
Holding Weightings of Gregory A Deener
Gregory A Deener Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory A Deener has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 19 shares on May 27, 2010, which cost Gregory A Deener around $54,270.
Insider Trading History of Gregory A Deener
- 1
Gregory A Deener Trading Performance
GuruFocus tracks the stock performance after each of Gregory A Deener's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory A Deener is 23.31%. GuruFocus also compares Gregory A Deener's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory A Deener within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory A Deener's insider trading performs compared to the benchmark.
Performance of Gregory A Deener
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.19 | | | | | |
| Relative Return to S&P 500(%) | 23.92 | | | | | |
Gregory A Deener Ownership Network
Ownership Network List of Gregory A Deener
Ownership Network Relation of Gregory A Deener
Gregory A Deener Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Gregory A Deener is the Vice President of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Gregory A Deener made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 28,000 shares made by Gunnar F. Kaufmann , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 12,380 shares were bought by its insiders, resulting in a net purchase of 11,400 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Gregory A Deener Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory A Deener. You might contact Gregory A Deener via mailing address: 175 Toyota Plaza, 7th Floor, Memphis Tn 38103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
